Improving Treatment Outcomes in Pharmacotherapy of Generalized Social Anxiety Disorder
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Mark H. Pollack, MD
Massachusetts General Hospital
Principal Investigator - Michael Van Ameringen, MD, FRCPC
Anxiety Disorders Clinic McMaster University Medical Centre
Principal Investigator - Murray B. Stein, MD, MPH
University of California San Deigo
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Mcmaster University Medical Centre Anxiety Disorders Clinic
Hamilton, Ontario, Canada
- University of California San Diego
La Jolla, California, United States
- Center for Anxiety and Traumatic Stress Disorders
Boston, Massachusetts, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2006
- Primary completion
- 31 Dec 2011
- Completion
- 31 Dec 2011
- Last update posted
- 14 Oct 2013
- Registered enrollment
- 397
- Registry id
- NCT00282828
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.